Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia

Our study uncovers an interplay between the cytokine milieu and transcriptional programs that extends a developmental window of permissiveness to transformation by the ETO2::GLIS2 AML fusion oncogene, controls the intratumoral cellular heterogeneity, and offers a ground-breaking therapeutical opportunity by a targeted combination strategy.

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2024-09-20
DOI
https://doi.org/10.1186/s12943-024-02110-y
Citations
2
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia

Erika Brunet, Fabien Boudia, Thomas Mercher, Guillaume Piton et al.
2 citations
Molecular Cancer
Acute Myeloid Leukemia Research
0.91
article

Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia

Erika Brunet, Fabien Boudia, Thomas Mercher, Guillaume Piton, Vilma Barroca, Nasséra Abermil, Zakia Aid, Laurent Renou, Virginie Rouiller‐Fabre, Arnaud Petit, Verónica Alonso-Pérez, Hélène Lapillonne, Paola Ballerini, Didier Busso, Françoise Pflumio, Delphine Moison, Pierre Hirsch, Jelena Martinović, Rima Haddad, Saryiami Devanand, Christophe Metereau, Elie Robert, Loélia Babin, Klaudia Galant
article en
2 citations

Abstract

Our study uncovers an interplay between the cytokine milieu and transcriptional programs that extends a developmental window of permissiveness to transformation by the ETO2::GLIS2 AML fusion oncogene, controls the intratumoral cellular heterogeneity, and offers a ground-breaking therapeutical opportunity by a targeted combination strategy.

Molecular CancerVol. 23(1)
Inserm (FR), Université Paris Cité (FR), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Sorbonne Université (FR), Hôpital Armand-Trousseau (FR), Acute Leukemia French Association (FR), La Ligue Contre le Cancer (FR), CEA Paris-Saclay - Etablissement de Fontenay-aux-roses (FR), Assistance Publique – Hôpitaux de Paris (FR), CEA Paris-Saclay (FR), Centre de Recherche Saint-Antoine (FR), Hôpital Antoine-Béclère (FR)
Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Institut National Du Cancer, Institut Gustave-Roussy, Institut Carnot Santé Animale
Good health and well-being
Openalex Percentile: Top 23%
Acute Myeloid Leukemia Research
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.